Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Long-term follow-up of a patient with malignant transformation of inverted papilloma into sinonasal undifferentiated carcinoma.

Orgain CA, Shibuya TY, Thompson LD, Keschner DB, Garg R, Lee JT.

Allergy Rhinol (Providence). 2017 Oct 1;8(3):173-177. doi: 10.2500/ar.2017.8.0209.

2.

Ossifying fibroma of the maxilla and sinonasal tract: Case series.

Liu JJ, Thompson LD, Janisiewicz AM, Shibuya TY, Keschner DB, Garg R, Lee JT.

Allergy Rhinol (Providence). 2017 Mar 1;8(1):32-36. doi: 10.2500/ar.2017.8.0190.

3.

Clinicopathological and Targeted Exome Gene Features of a Patient with Metastatic Acinic Cell Carcinoma of the Parotid Gland Harboring an ARID2 Nonsense Mutation and CDKN2A/B Deletion.

Warner WA, Wong DJ, Palma-Diaz F, Shibuya TY, Momand J.

Case Rep Oncol Med. 2015;2015:893694. doi: 10.1155/2015/893694. Epub 2015 Nov 8.

4.

Craniocervical necrotizing fasciitis resulting from dentoalveolar infection.

Brunworth J, Shibuya TY.

Oral Maxillofac Surg Clin North Am. 2011 Aug;23(3):425-32. doi: 10.1016/j.coms.2011.04.007. Review.

PMID:
21798441
5.

Release kinetics of polymer-bound bone morphogenetic protein-2 and its effects on the osteogenic expression of MC3T3-E1 osteoprecursor cells.

Gharibjanian NA, Chua WC, Dhar S, Scholz T, Shibuya TY, Evans GR, Calvert JW.

Plast Reconstr Surg. 2009 Apr;123(4):1169-77. doi: 10.1097/PRS.0b013e31819f2987.

PMID:
19337085
6.

Cell carcinoma of the paranasal sinuses and skull base.

McKay SP, Shibuya TY, Armstrong WB, Wong HS, Panossian AM, Ager J, Mathog RH.

Am J Otolaryngol. 2007 Sep-Oct;28(5):294-301.

PMID:
17826529
7.

Facial fracture repair in the traumatic brain injury patient.

Shibuya TY, Karam AM, Doerr T, Stachler RJ, Zormeier M, Mathog RH, McLaren CL, Li KT.

J Oral Maxillofac Surg. 2007 Sep;65(9):1693-9.

PMID:
17719385
8.

Burkitt's lymphoma of the base of the tongue: a case report and review of the literature.

Feinberg SM, Ou SH, Gu M, Shibuya TY.

Ear Nose Throat J. 2007 Jun;86(6):356-60. Review.

PMID:
17703817
9.

Functional outcomes of the retromaxillary-infratemporal fossa dissection for advanced head and neck/skull base lesions.

Shibuya TY, Doerr TD, Mathog RH, Burgio DL, Meleca RJ, Yoo GH, Guthikonda M.

Skull Base Surg. 2000;10(3):109-17.

10.

Optical coherence tomography of laryngeal cancer.

Armstrong WB, Ridgway JM, Vokes DE, Guo S, Perez J, Jackson RP, Gu M, Su J, Crumley RL, Shibuya TY, Mahmood U, Chen Z, Wong BJ.

Laryngoscope. 2006 Jul;116(7):1107-13.

PMID:
16826043
11.

Visual risks of facial fracture repair in the setting of traumatic optic neuropathy.

Shibuya TY, Feinberg SM, Mathog RH, Li KT, Kim SA, Stachler RJ, Yoo GH.

Arch Otolaryngol Head Neck Surg. 2006 Mar;132(3):258-64.

PMID:
16549745
12.

Linking of bone morphogenetic protein-2 to resorbable fracture plates for enhancing bone healing.

Shibuya TY, Wadhwa A, Nguyen KH, Panossian AM, Kim S, Wong H, Feinberg S, Damisah EC, Camilon PR, Bang H.

Laryngoscope. 2005 Dec;115(12):2232-7.

PMID:
16369172
13.

In vivo optical coherence tomography of the human larynx: normative and benign pathology in 82 patients.

Wong BJ, Jackson RP, Guo S, Ridgway JM, Mahmood U, Su J, Shibuya TY, Crumley RL, Gu M, Armstrong WB, Chen Z.

Laryngoscope. 2005 Nov;115(11):1904-11. Erratum in: Laryngoscope. 2006 Mar;116(3):507.

PMID:
16319597
14.

An in vivo evaluation of docetaxel delivered intratumorally in head and neck squamous cell carcinoma.

Yoo GH, Subramanian G, Boinpally RR, Iskander A, Shehadeh N, Oliver J, Ezzat W, Piechocki MP, Ensley JF, Lin HS, Shibuya TY, Polin L, Parchment RE.

Arch Otolaryngol Head Neck Surg. 2005 May;131(5):418-29. Erratum in: Arch Otolaryngol Head Neck Surg. 2006 Nov;132(11):1188.

PMID:
15897421
15.

Prognostic significance of G1 cell-cycle inhibitors in early laryngeal cancer.

Korkmaz H, Du W, Yoo GH, Enamorado II, Lin HS, Adsay V, Kewson D, Ensley JF, Shibuya TY, Jacobs JR, Kim H.

Am J Otolaryngol. 2005 Mar-Apr;26(2):77-82.

PMID:
15742257
16.

Enhancement of Ad-p53 therapy with docetaxel in head and neck cancer.

Yoo GH, Piechocki MP, Oliver J, Lonardo F, Zumstein L, Lin HS, Kim H, Shibuya TY, Shehadeh N, Ensley JF.

Laryngoscope. 2004 Nov;114(11):1871-9.

PMID:
15510008
17.

Bioactive suture: a novel immunotherapy for head and neck cancer.

Shibuya TY, Kim S, Nguyen K, Do J, McLaren CE, Li KT, Chen WP, Parikh P, Wadhwa A, Zi X, Chen VY, Wong HS, Armstrong WB, Yoo GH.

Clin Cancer Res. 2004 Oct 15;10(20):7088-99.

18.

Covalent linking of proteins and cytokines to suture: enhancing the immune response of head and neck cancer patients.

Shibuya TY, Kim S, Nguyen K, Parikh P, Wadhwa A, Brockardt C, Do J.

Laryngoscope. 2003 Nov;113(11):1870-84. Review.

PMID:
14603040
19.

Docetaxel induced gene expression patterns in head and neck squamous cell carcinoma using cDNA microarray and PowerBlot.

Yoo GH, Piechocki MP, Ensley JF, Nguyen T, Oliver J, Meng H, Kewson D, Shibuya TY, Lonardo F, Tainsky MA.

Clin Cancer Res. 2002 Dec;8(12):3910-21.

20.

In vivo characteristics of HPV-immortalized and carcinogen transformed oral keratinocytes.

Yoo GH, Piechocki MP, Lonardo F, Meng H, Kewson D, Shibuya TY, Kim H, Stachler R, Ensley JF.

Laryngoscope. 2002 Sep;112(9):1672-9.

PMID:
12352685
21.

Clinical significance of poor CD3 response in head and neck cancer.

Shibuya TY, Nugyen N, McLaren CE, Li KT, Wei WZ, Kim S, Yoo GH, Rogowski A, Ensley J, Sakr W.

Clin Cancer Res. 2002 Mar;8(3):745-51.

22.

The effects of exogenous p53 overexpression on HPV-immortalized and carcinogen transformed oral keratinocytes.

Yoo GH, Washington J, Oliver J, Piechocki M, Kim H, Foster-Nora J, Shibuya TY, Wilson DR, Ensley JF.

Cancer. 2002 Jan 1;94(1):159-66.

23.

Prognostic factors in major salivary gland cancer.

Hocwald E, Korkmaz H, Yoo GH, Adsay V, Shibuya TY, Abrams J, Jacobs JR.

Laryngoscope. 2001 Aug;111(8):1434-9.

PMID:
11568581
24.

Craniocervical necrotizing fasciitis: an 11-year experience.

Bahu SJ, Shibuya TY, Meleca RJ, Mathog RH, Yoo GH, Stachler RJ, Tyburski JG.

Otolaryngol Head Neck Surg. 2001 Sep;125(3):245-52.

PMID:
11555761
25.

Titanium mesh repair of the severely comminuted frontal sinus fracture.

Lakhani RS, Shibuya TY, Mathog RH, Marks SC, Burgio DL, Yoo GH.

Arch Otolaryngol Head Neck Surg. 2001 Jun;127(6):665-9.

PMID:
11405865
26.

Anti-CD3/anti-CD28 bead stimulation overcomes CD3 unresponsiveness in patients with head and neck squamous cell carcinoma.

Shibuya TY, Wei WZ, Zormeier M, Ensley J, Sakr W, Mathog RH, Meleca RJ, Yoo GH, June CH, Levine BL, Lum LG.

Arch Otolaryngol Head Neck Surg. 2000 Apr;126(4):473-9.

PMID:
10772300
27.

Anti-CD3/anti-CD28 monoclonal antibody-coated suture enhances the immune response of patients with head and neck squamous cell carcinoma.

Shibuya TY, Wei WZ, Zormeier M, Ensley J, Sakr W, Mathog RH, Meleca RJ, Yoo G, June CH, Levine B, Lum LG.

Arch Otolaryngol Head Neck Surg. 1999 Nov;125(11):1229-34.

PMID:
10555694
28.

Squamous cell carcinoma of the supraglottic larynx in a patient with Fanconi's anemia.

Doerr TD, Shibuya TY, Marks SC.

Otolaryngol Head Neck Surg. 1998 Apr;118(4):523-5. Review. No abstract available.

PMID:
9560105
29.

Sinus disease in the bone marrow transplant population: incidence, risk factors, and complications.

Shibuya TY, Momin F, Abella E, Jacobs JR, Karanes C, Ratanatharathorn V, Sensenbrenner LL, Lum LG.

Otolaryngol Head Neck Surg. 1995 Dec;113(6):705-11.

PMID:
7501381

Supplemental Content

Loading ...
Support Center